Overview

Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease

Status:
Terminated

Trial end date:
2019-07-04

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if multiple immunizations with Lu AF20513 is tolerable and safe in patients with mild Alzheimer's disease.

Phase:

Phase 1

Details

Lead Sponsor:

H. Lundbeck A/S